Preventing blindness by
improving retinal therapy
Preventing blindness by improving retinal therapy
deepeye empowers ophthalmologists to provide individual therapy to patients suffering from retinal eye diseases like Age-related Macular Degeneration (AMD) and others with a prevalence of >12% in the European and US population, thus preventing the causes of more than 90% of blindness‘.
Treatment of retinal diseases is complex, costly and hardly allows individual treatment of patients
By developing AI tools for ophthalmology, we plan to significantly improve the therapy process for patients and doctors.